WE THE PEOPLE - Building a New Democracy in Nigeria as a Model for Africa
| Publisher Name | Prof. Peter U. Nwangwu Pharm.D. PH.D. |
|---|---|
| Author Name | Hagendorf, Col |
| Format | Audio |
| Bisac Subject Major | POL |
| Language | NG |
| Isbn 10 | 0997956607 |
| Isbn 13 | 9780997956603 |
| Target Age Group | min:NA, max:NA |
| Dimensions | 00.90" H x 20.05" L x 98.00" W |
| Page Count | 416 |
Every medical scientist who uses the murine model of human cardiomyopathy for studies in cardiovascular disease worldwide today has benefited from the invention of Dr. Peter U. Nwangwu who documented and published the first in-vivo murine ventricular tachycardia in a single surface electrocardiogram lead. Renowned scientists such as professors at Harvard medical school who currently use this model quote him in their research publications as the medical scientist who first documented and published murine ventricular tachycardia. He has invented and published two new techniques in pharmacology used worldwide, including a new technique for identification of time of myocardial infarction, and a new reliable technique for screening antiarrhythmic drugs, which received worldwide acceptance and became popular worldwide. He also developed seven new antiarrhythmic drugs which are protected by U.S patents. Nwangwu is a transformational leader with preeminent abilities to craft and implement new methods of doing things better, a strategic thinker practiced in compelling visions and creative initiatives. He is an exceptional individual with distinguished educational and intellectual capacity and achievements, who thrives in a complex environment, and is excellent with multi-tasking. After completion of his Pharm.D., Ph.D. degrees at University of Nebraska, Nwangwu accepted a position as Director of Clinical Research & Assistant Professor of Pharmacology and Toxicology at Florida A & M University in 1979. In 1981 he was appointed Associate Professor of Pharmacology and Toxicology at St. John's University New York. In 1983 he joined the world HQ of drug company, Ayerst Laboratories, division American Home Products, in Manhattan New York as Clinical Research Administrator. He started the first FDA registered & inspected drug manufacturing company owned by a black man in America. Nwangwu has received many awards & honors, including being listed in more than 24 reference books. In 2006, he was honored in the U.S as the recipient of "The 2006 Congressional Medal of Distinction". In 2005, he was decorated with 3 meritorious awards: "The 2005 President Ronald Reagan Republican Gold Medal"; "Man of the Year 2005"; and "Businessman of the Year 2005". In 2008, his Alma mater selected him as "The 2008 Outstanding International Alumnus of University of Nebraska".
